Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Oficinas extranjeras
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Divisiones operativas
      • División de Aviación
      • División de Control de Desvíos
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Lo que hacemos
    • Orden público
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Educación y prevención
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Información sobre las drogas
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Carreras
    • Agentes especiales
      • Preguntas frecuentes de los agentes especiales
      • Anuncios de empleo para agentes especiales
    • Investigador de desvíos
      • Diversion Investigator Job Announcement
    • Especialista en investigación de inteligencia
      • Anuncios de trabajo de especialista en investigación de inteligencia
      • Preguntas frecuentes de los especialistas en investigación de inteligencia
      • Autoridad de contratación de la Categoría A: Especialista en investigación de inteligencia
    • Carreras de ciencias forenses
    • Carreras profesionales y administrativas
    • Carreras para estudiantes y de nivel básico
    • Cómo aplicar
      • Empleador con igualdad de oportunidades
      • Requisitos de empleo
      • Cómo reclamar la preferencia de los veteranos
      • Consideración prioritaria
      • Beneficios
      • Veteranos y personas con discapacidades
  • Recursos
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • Ley de Libertad de Información
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Buscar
  • Menú Completo

Main Menu

  • Quiénes somos
  • Lo que hacemos
  • Carreras
  • Recursos
  • Recibir Actualizaciones
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Frank A. Tarentino III Special Agent in Charge
New York
@DEANewYorkDiv
Diciembre 09, 2022
Contact:
Phone Number: (212) 337-3900
For Immediate Release

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

MANHATTAN –   Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a scheme that involved obtaining oxycodone, Adderall, Klonopin and Suboxone pills in Manhattan to illegally sell in Staten Island.

The defendants are charged in three New York State Supreme Court indictments that were the result of a yearlong wiretap investigation by the Manhattan District Attorney’s Office, the New York City Police Department, the Business Integrity Commission, the Waterfront Commission of New York Harbor, and the New York Strike Force Tactical Diversion Squad. 

“As alleged, these defendants used the ongoing opioid crisis to exploit the suffering and addiction of others. And to make matters worse, a trusted Manhattan doctor prescribed pills to the defendants, which were then sold illegally to New Yorkers,” said District Attorney Bragg. “We are grateful for the collaboration with our law enforcement partners and will continue to work across agencies to hold accountable all who make our streets less safe and endanger the lives of New Yorkers with illicit prescription drugs.”

“Today’s charges prove again that New York City’s fight against the illegal drug trade is unrelenting,” said NYPD Commissioner Keechant L. Sewell. “The NYPD, together with all of our law-enforcement partners, will pursue these criminals however they operate – and when the perpetrators are trusted members of the medical community, their crimes are especially appalling. I thank and commend the Manhattan District Attorney’s office, the NYC Business Integrity Commission, the Waterfront Commission of New York Harbor, the DEA’s New York Division, and everyone else involved in this case for their exceptional work.”

“This investigation demonstrates how the diversion of prescription medication precipitates drug peddling throughout our communities,” said DEA Special Agent in Charge Frank Tarentino. “Investigators learned that Dr. Noel Smith prescribed controlled substances in a manner inconsistent with public health and safety which put many people in harm’s way. I want to thank our law enforcement partners who worked collectively on this significant investigation.”  

“BIC values working in partnership with NYPD, Manhattan DA’s Office, the DEA’s New York Division and the Waterfront Commission of New York Harbor and our collective continued efforts to work as partners in public safety,” said BIC Commissioner and Chair Elizabeth Crotty.

“The Waterfront Commission of New York Harbor remains committed to working with all its law enforcement partners to eliminate the scourge of illegal narcotics in the Port District and elsewhere in the metropolitan area, especially when it involves organized crime” said Waterfront Commission of New York Harbor New York Executive Director Walter Arsenault. “We thank the New York County District Attorney’s Office for their work on this case and for our continued partnership in keeping the public safe.”

Smith, a Tribeca-based family practitioner, is charged with numerous counts of Criminal Sale of a Prescription for a Controlled Substance by a Practitioner for writing prescriptions for Adderall, Klonopin and Suboxone to Timothy Bonaguro, Christopher Gorga, Ivan Iorizzo, Mark, Lanfranchi, and Louis Ventafredda.  

Along with associate Anthony Santo, Bonaguo, Gorga, Iorizzo, Lanfranchi, and Ventafredda are charged with Conspiracy in the Fifth Degree and numerous counts of Criminal Possession of a Controlled Substance in the Fifth Degree for participating in a scheme to obtain and fill the prescriptions from Smith and distribute the pills through illegal street-level sales to buyers on Staten Island. 

To build up an inventory of pills, Iorizzo, Lanfranchi and Ventafredda designed a plan that would maximize their hauls:

Iorizzo obtained prescriptions in his name for Adderall, Klonopin and Suboxone.

Bonaguro and Gorga obtained prescriptions in their names for Adderall and Klonopin.

Iorizzo, Lanfranchi and Ventafredda would assume the identity of one of Iorizzo's brothers for Adderall and Klonopin prescriptions.

Iorizzo, Lanfranchi and Santo would assume the identity of another one of Iorizzo’s brothers for Adderall and Klonopin prescriptions.

Iorizzo, Lanfranchi, Santo, and Ventafredda are also charged with Identity Theft in the First Degree for impersonating Iorizzo's brothers in order to obtain extra inventory of pills to sell. 

In a separate indictment, Iorizzo and Ventafredda are charged along with Elia Albanese and Carmine Russo with Conspiracy in the Fourth Degree and numerous counts of Criminal Possession of a Controlled Substance in the Third Degree for participating in a scheme to obtain oxycodone pills from a different Midtown Manhattan doctor and illegally sell the pills. Iorizzo and Ventafredda carried out a similar scheme for building inventory.  

Albanese and Russo obtained prescriptions in their names for oxycodone from the midtown doctor in their names and would get them filled in Manhattan. Iorizzo and Ventafredda would then run the pills obtained by Albanese and Russo so that Iorizzo  and associates could then sell the oxycodone on Staten Island.

Assistant D.A.s Anne Ternes and Mao Yu Lin are handling the prosecution of this case under the supervision of Assistant District Attorney Julieta V. Lozano (Chief of the Major Economic Crimes Bureau), Executive Assistant D.A.s Christopher Conroy (Senior Advisor to the Investigation Division) and Susan Hoffinger (Investigation Division Chief). Assistant District Attorney Sun Moon Heo, Office of the Special Narcotics Prosecutor; Senior Financial Investigator Robert Pomeroy and former Senior Financial Investigator Evelyn Marrero; Rackets Investigators Robert Mistretta, Daniel Frooks, and Shannon Rowe; Investigative Analysts L. Jackson Howell and Benjamin Kobrin; Trial Preparation Assistants William Briskin, Miranda Coombe, and Georgia Longstreet Joseph; and former Investigative Analysts Alessandro Schooley, Lauren Davila, Sloane Ruffa, and Anna Bruckner, also provided assistance with the investigation.

District Attorney Bragg thanked the Criminal Enterprise Investigation Section of the New York City Police Department, especially Detective Brian O’Keeffe, New York Strike Force- Tactical Diversion Squad, the Business Integrity Commission, especially Matthew Gonzalez, Deputy Director of IT and Chief Information Security Officer, the Waterfront Commission of New York Harbor, the New York State Bureau of Narcotic Enforcement, and the Office of the Special Narcotics Prosecutor for their assistance with the investigation. District Attorney Bragg also thanked the New York State Department of Health for providing continuity of care for patients of Smith.

Defendant Information

ELIA ALBANESE
New York, NY
Charges:

Criminal Possession of a Controlled Substance in the Third Degree, a class B felony, nine counts

Conspiracy in the Fourth Degree, a class E felony, one count

TIMOTHY BONAGURO
Parlin, NJ
Charges:

Criminal Possession of a Controlled Substance in the Fifth Degree, a class D felony, eight counts

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

CHRISTOPHER GORGA
Matawan, NJ
Charges:

Criminal Possession of a Controlled Substance in the Fifth Degree, a class D felony, four counts

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

IVAN IORIZZO
Staten Island, NY
Charges:

Criminal Possession of a Controlled Substance in the Third Degree, a class B felony, four counts

Criminal Possession of a Controlled Substance in the Fifth Degree, a class D felony, 59 counts

Conspiracy in the Fourth Degree, a class E felony, one count

Attempted Criminal Possession of a Controlled Substance in the Fifth Degree, a class E felony, two counts

Identity Theft in the First Degree, a class D felony, 15 counts

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

MARK LANFRANCHI
Morganville, NJ
Charges:

Criminal Possession of a Controlled Substance in the Fifth Degree, a class D felony, 57 counts

Identity Theft in the First Degree, a class D felony, 13 counts, D felony

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

CARMINE RUSSO
New York, NY
Charges:

Criminal Possession of a Controlled Substance in the Third Degree, a class B felony, eight counts

Conspiracy in the Fourth Degree, a class E felony, one count

ANTHONY SANTO
Staten Island, NY
Charges:

Criminal Possession of a Controlled Substance in the Fifth Degree, a D felony, 12 counts

Identity Theft in the First Degree, a class D felony, six counts

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

NOEL SMITH, M.D.
New York, NY
Charges:

Criminal Sale of a Prescription for a Controlled Substance by a Practitioner, a class C felony, 30 counts

LOUIS VENTAFREDDA
Staten Island, NY
Charges:

Criminal Possession of a Controlled Substance in the Third Degree, a class B felony, 17 counts

Criminal Possession of a Controlled Substance in the Fifth Degree, a class D felony, 14 counts

Conspiracy in the Fourth Degree, a class E felony, one count

Attempted Criminal Possession of a Controlled Substance in the Fifth Degree, a class E felony, two counts

Identity Theft in the First Degree, a class D felony, eight counts

Conspiracy in the Fifth Degree, a class A misdemeanor, one count

The charges contained in the indictment are merely allegations, and the defendant is presumed innocent unless and until proven guilty. All factual recitations are derived from documents filed in court and statements made on the record in court.

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Divisiones Nacionales
    • Oficinas Extranjeras
    • Contáctenos
    • Museo DEA
  • Lo Que Hacemos
    • Prevención de Drogas
    • Aplicacion de la Ley
    • División de Control de Desvío
    • Noticias
  • Carreras
    • Resumen
    • Agente Especial
    • Investigador de Desvío
    • Especialista en Investigación de Inteligencia
  • Recursos
    • Información sobre las Drogas
    • Programa de Asistencia al Empleado
    • Empleador con Igualdad de Oportunidades
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Hacer Negocios
    con la DEA
    • Resumen
    • Proveedores Actuales
    • Futuros Vendedores
    • Cláusulas de Seguridad
    • Formularios de Seguridad
    • Programa de Pequeñas Empresas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
Inicio

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster